Understanding Participation in Recurrent Ovarian Cancer Trials
This study is looking at how people with recurrent ovarian cancer decide to join clinical trials and how long they stay involved. It's an observational study, meaning researchers will watch and learn without giving any specific treatments. They want to understand why some patients choose to participate and others don't, and what helps them complete a trial. You can join if you are 18 or older, have recurrent ovarian cancer, and can understand the study and report information electronically. The goal is to learn more about how to improve participation in future research for this condition. This study aims to enroll 500 participants.
- Study design
- This is an observational study, meaning researchers will gather information without providing any specific treatments. It plans to include 500 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Researchers will track how many patients decide to join a trial at 3 months, and how many remain in research until completion at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of patients who decide to participate in a recurrent ovarian cancer clinical trial3 months
- Rate of patients who remain in recurrent ovarian cancer clinical research to trial completion12 months